UK markets open in 7 hours 30 minutes
NIKKEI 225
38,229.11 -44.99 (-0.12%) HANG SENG
18,963.68 +487.78 (+2.64%) CRUDE OIL
78.05 -0.21 (-0.27%) GOLD FUTURES
2,367.80 -7.20 (-0.30%) DOW
39,512.84 +837.14 (+2.16%) Bitcoin GBP
48,980.04 +310.85 (+0.64%)
CytomX Therapeutics, Inc. (6C1.F)
Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
At close: 04:10PM CEST
Currency in EUR
Valuation measures4
| Market cap (intra-day) | 143.12M |
| Enterprise value | -5.80M |
| Trailing P/E | N/A |
| Forward P/E | 19.23 |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 1.40 |
| Price/book (mrq) | 4.76 |
| Enterprise value/revenue | -0.41 |
| Enterprise value/EBITDA | 0.31 |
Trading information
Stock price history
| Beta (5Y monthly) | N/A |
| 52-week change 3 | 10.81% |
| S&P500 52-week change 3 | 26.27% |
| 52-week high 3 | 4.4020 |
| 52-week low 3 | 0.9760 |
| 50-day moving average 3 | 2.1386 |
| 200-day moving average 3 | 1.5164 |
Share statistics
| Avg vol (3-month) 3 | 732 |
| Avg vol (10-day) 3 | 3.05k |
| Shares outstanding 5 | 68.14M |
| Implied shares outstanding 6 | 70.3M |
| Float 8 | 61.94M |
| % held by insiders 1 | 1.03% |
| % held by institutions 1 | 43.77% |
| Shares short 4 | N/A |
| Short ratio 4 | N/A |
| Short % of float 4 | N/A |
| Short % of shares outstanding 4 | N/A |
| Shares short (prior month ) 4 | N/A |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Currency in USD.Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | 13.87% |
| Operating margin (ttm) | 28.11% |
Management effectiveness
| Return on assets (ttm) | 3.23% |
| Return on equity (ttm) | N/A |
Income statement
| Revenue (ttm) | 119.18M |
| Revenue per share (ttm) | 1.53 |
| Quarterly revenue growth (yoy) | 76.40% |
| Gross profit (ttm) | N/A |
| EBITDA | 12.87M |
| Net income avi to common (ttm) | 16.53M |
| Diluted EPS (ttm) | -0.0100 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 150.28M |
| Total cash per share (mrq) | 1.93 |
| Total debt (mrq) | 12.87M |
| Total debt/equity (mrq) | N/A |
| Current ratio (mrq) | 1.16 |
| Book value per share (mrq) | -0.41 |
Cash flow statement
| Operating cash flow (ttm) | -91.43M |
| Levered free cash flow (ttm) | 30.25k |
© 2024 Yahoo. All rights reserved.